What Analysts Predict For Neovasc Inc. ($NVCN) 3Q20?

88

Neovasc Inc. (NASDAQ:NVCN) is reporting third quarter financial results on Thursday 5th November 2020, after market close.

Stock Performance

Shares of Neovasc Inc. traded low $ -0.05 or -6.10 percent on Wednesday, reaching $ 0.76 with volume of 410.60 thousand shares. Neovasc Inc. has traded high as $ 0.80 and has cracked $ 0.75 on the downward trend

The closing price of $ 0.76, representing a 8.00 % increase from the 52 week low of $ 0.75 and a 90.64 % decrease over the 52 week high of $ 8.65.

The company has a market capital of $ 16.69 million and is part of the Healthcare sector and Medical Devices industry.

Conference Call

Neovasc Inc. will be hosting a conference call at 4:30 PM eastern time on 5th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.neovasc.com

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp.